130 related articles for article (PubMed ID: 8575100)
1. Abnormal auditory P300 topography in attention deficit disorder predicts poor response to pemoline.
Sangal JM; Sangal RB; Persky B
Clin Electroencephalogr; 1995 Oct; 26(4):204-13. PubMed ID: 8575100
[TBL] [Abstract][Full Text] [Related]
2. Prolonged P300 latency in attention deficit hyperactivity disorder predicts poor response to imipramine.
Sangal JM; Sangal RB; Persky B
Clin Electroencephalogr; 1996 Oct; 27(4):191-201. PubMed ID: 9465283
[TBL] [Abstract][Full Text] [Related]
3. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) topography predicts treatment response to methylphenidate.
Sangal RB; Sangal JM
Clin Neurophysiol; 2004 Jan; 115(1):188-93. PubMed ID: 14706487
[TBL] [Abstract][Full Text] [Related]
4. Attention-deficit/hyperactivity disorder: cognitive evoked potential (P300) amplitude predicts treatment response to atomoxetine.
Sangal RB; Sangal JM
Clin Neurophysiol; 2005 Mar; 116(3):640-7. PubMed ID: 15721078
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
Sangal RB; Sangal JM
Clin Neurophysiol; 2006 Sep; 117(9):1996-2006. PubMed ID: 16890481
[TBL] [Abstract][Full Text] [Related]
6. Pemoline in ADHD.
Winsberg B; Barbato M
J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321
[No Abstract] [Full Text] [Related]
7. Photic responses in "minimal brain dysfunction".
Milstein V; Small JG
Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
[No Abstract] [Full Text] [Related]
8. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial.
Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M
J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410
[TBL] [Abstract][Full Text] [Related]
9. Compliance with FDA recommendations for pemoline.
Sarkis EH
J Am Acad Child Adolesc Psychiatry; 2003 Apr; 42(4):383; author reply 383. PubMed ID: 12649623
[No Abstract] [Full Text] [Related]
10. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents.
Riggs PD; Hall SK; Mikulich-Gilbertson SK; Lohman M; Kayser A
J Am Acad Child Adolesc Psychiatry; 2004 Apr; 43(4):420-9. PubMed ID: 15187802
[TBL] [Abstract][Full Text] [Related]
11. Pemoline therapy in college students with attention deficit hyperactivity disorder: a retrospective study.
Heiligenstein E; Johnston HF; Nielsen JK
J Am Coll Health; 1996 Jul; 45(1):35-9. PubMed ID: 8708264
[TBL] [Abstract][Full Text] [Related]
12. Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.
Sangal RB; Sangal JM
Expert Rev Neurother; 2006 Oct; 6(10):1429-37. PubMed ID: 17078784
[TBL] [Abstract][Full Text] [Related]
13. Medication for attention deficit hyperactivity disorder: commentary and response.
Faigel HC; Heiligenstein E
J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265
[No Abstract] [Full Text] [Related]
14. An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder.
Riggs PD; Thompson LL; Mikulich SK; Whitmore EA; Crowley TJ
J Am Acad Child Adolesc Psychiatry; 1996 Aug; 35(8):1018-24. PubMed ID: 8755798
[TBL] [Abstract][Full Text] [Related]
15. EEG and clinical findings during pemoline treatment in children and adults with attention deficit disorder. An 8-week open trial.
Caresia L; Pugnetti L; Besana R; Barteselli F; Guareschi Cazzullo A; Musetti L; Scarone S
Neuropsychobiology; 1984; 11(3):158-67. PubMed ID: 6472603
[TBL] [Abstract][Full Text] [Related]
16. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
Rao JK; Julius JR; Breen TJ; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
[TBL] [Abstract][Full Text] [Related]
17. [Attention deficit hyperactivity disorder in children].
Bervoets L
J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
[No Abstract] [Full Text] [Related]
18. Attention deficit hyperactivity in adults.
Cubbin S; Leahy A
Br J Psychiatry; 1998 Apr; 172():366. PubMed ID: 9715347
[No Abstract] [Full Text] [Related]
19. Topography of auditory and visual P300 in normal adults.
Sangal B; Sangal JM
Clin Electroencephalogr; 1996 Jul; 27(3):145-50. PubMed ID: 8828977
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder.
Wilens TE; Biederman J; Spencer TJ; Frazier J; Prince J; Bostic J; Rater M; Soriano J; Hatch M; Sienna M; Millstein RB; Abrantes A
J Clin Psychopharmacol; 1999 Jun; 19(3):257-64. PubMed ID: 10350032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
